Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Acid Attack on Concrete01:21

Acid Attack on Concrete

788
When acids come into contact with concrete, they initiate a chemical reaction that dissolves the hydrated cement paste. This process leads to softening and structural weakening of the concrete. This issue is commonly observed in environments such as chimneys, sewers, and industrial settings. The severity of the damage increases as the pH of the water interacting with the concrete drops below 6.5. In particular, a pH under 4.5 can cause significant concrete damage.
The rate at which hydrogen...
788
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

2
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Denosumab, a rank ligand inhibitor for prevention of skeletal-related events due to bone metastases from solid tumors in adults.

Oncology (Williston Park, N.Y.)·2014
Same author

Metastatic colorectal cancer: management challenges and opportunities.

Oncology (Williston Park, N.Y.)·2014
Same author

Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma.

Oncology (Williston Park, N.Y.)·2014
Same author

Eribulin, a microtubule inhibitor for metastatic breast cancer.

Oncology (Williston Park, N.Y.)·2014
Same author

Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinoma.

Oncology (Williston Park, N.Y.)·2014
Same author

Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer.

Oncology (Williston Park, N.Y.)·2011

Related Experiment Video

Updated: Feb 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents.

Gail M Wilkes1

  • 1Oncology Nursing Consultant, Kilauea, HI, USA.

Asia-Pacific Journal of Oncology Nursing
|April 3, 2018
PubMed
Summary

Personalized cancer therapy uses targeted drugs to treat patients. This review covers FDA-approved molecular and immune agents in the USA, with nursing implications discussed.

Keywords:
Cancerimmunologicalmoleculartargeted agentstargeted therapy

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Related Experiment Videos

Last Updated: Feb 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Personalized cancer therapy is a leading treatment approach.
  • Advances in understanding cancer genetics and immune evasion are driving new therapies.
  • Targeted agents offer individualized treatment strategies.

Purpose of the Study:

  • To provide a simplified overview of FDA-approved molecular and immunological targeted agents in the USA.
  • To review nursing implications for these drug classes.

Main Methods:

  • Review of available Food and Drug Administration (FDA)-approved targeted agents.
  • Focus on molecularly and immunologically targeted therapies.
  • Inclusion of nursing implications for different drug classes.

Main Results:

  • Overview of current FDA-approved targeted agents for cancer treatment in the USA.
  • Identification of key drug classes and their mechanisms.
  • Discussion of nursing considerations for administering these therapies.

Conclusions:

  • Targeted agents represent a significant advancement in personalized cancer care.
  • Understanding available agents and their nursing implications is crucial for effective patient treatment.
  • Ongoing research continues to expand the landscape of cancer therapeutics.